Expression and Secretion of Human Proinsulin-B10 from Mouse Salivary Glands: Implications for the Treatment of Type I Diabetes Mellitus

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Rowzee, Anne M ^a   Perez Riveros, Paola J ^a   Zheng, Changyu ^a   Krygowski, Sarah ^a   Baum, Bruce J ^a   Cawley, Niamh X ^b  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GLUCOSE; PROINSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PAROTID GLAND; PROTEIN EXPRESSION; PROTEIN INDUCTION; SUBMANDIBULAR GLAND; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; BLOOD GLUCOSE; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMANS; LIVER; MALE; MICE; MICE, INBRED BALB C; PAROTID GLAND; PROINSULIN; SUBMANDIBULAR GLAND;

EID: 84875027061     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059222     Document Type: Article

References (47)

1. Cotrim AP, Mineshiba F, Sugito T, Samuni Y, Baum BJ (2006) Salivary gland gene therapy. Dent Clin North Am 50: 157-173, vii.
2. Voutetakis A, Cotrim AP, Rowzee A, Zheng C, Rathod T, et al. (2010) Systemic delivery of bioactive glucagon-like peptide 1 after adenoviral-mediated gene transfer in the murine salivary gland. Endocrinology 151: 4566-4572.
3. Baum B, Alevizos I, Zheng C, Cotrim AP, Liu S, et al. (2012) Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction. Proc Natl Acad Sci U S A (in press).
4. Baum BJ, Zheng C, Alevizos I, Cotrim AP, Liu S, et al. (2010) Development of a gene transfer-based treatment for radiation-induced salivary hypofunction. Oral Oncology 46: 4-8.
5. Zheng C, Nikolov NP, Alevizos I, Cotrim AP, Liu S, et al. (2010) Transient detection of E1-containing adenovirus in saliva after the delivery of a first-generation adenoviral vector to human parotid gland. J Gene Med 12: 3-10.
6. Isenman L, Liebow C, Rothman S, (1999) The endocrine secretion of mammalian digestive enzymes by exocrine glands. Am J Physiol 276: E223-232.
7. Perez P, Rowzee AM, Zheng C, Adriaansen J, Baum BJ, (2010) Salivary epithelial cells: an unassuming target site for gene therapeutics. The International Journal of Biochemistry & Cell Biology 42: 773-777.
8. He X, Goldsmith CM, Marmary Y, Wellner RB, Parlow AF, et al. (1998) Systemic action of human growth hormone following adenovirus-mediated gene transfer to rat submandibular glands. Gene Ther 5: 537-541.
9. Adriaansen J, Perez P, Goldsmith CM, Zheng C, Baum BJ, (2008) Differential sorting of human parathyroid hormone after transduction of mouse and rat salivary glands. Hum Gene Ther 19: 1021-1028.
10. Voutetakis A, Kok MR, Zheng C, Bossis I, Wang J, et al. (2004) Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics. Proc Natl Acad Sci U S A 101: 3053-3058.
11. Martinenghi S, Cusella De Angelis G, Biressi S, Amadio S, Bifari F, et al. (2002) Human insulin production and amelioration of diabetes in mice by electrotransfer-enhanced plasmid DNA gene transfer to the skeletal muscle. Gene Ther 9: 1429-1437.
12. Shaw JA, Delday MI, Hart AW, Docherty HM, Maltin CA, et al. (2002) Secretion of bioactive human insulin following plasmid-mediated gene transfer to non-neuroendocrine cell lines, primary cultures and rat skeletal muscle in vivo. J Endocrinol 172: 653-672.
13. Burkhardt BR, Parker MJ, Zhang YC, Song S, Wasserfall CH, et al. (2005) Glucose transporter-2 (GLUT2) promoter mediated transgenic insulin production reduces hyperglycemia in diabetic mice. FEBS Lett 579: 5759-5764.
14. Hsu PY, Yang YW, (2005) Effect of polyethylenimine on recombinant adeno-associated virus mediated insulin gene therapy. J Gene Med 7: 1311-1321.
15. Oh TK, Li MZ, Kim ST, (2006) Gene therapy for diabetes mellitus in rats by intramuscular injection of lentivirus containing insulin gene. Diabetes Res Clin Pract 71: 233-240.
16. Ren B, O'Brien BA, Swan MA, Koina ME, Nassif N, et al. (2007) Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy. Diabetologia 50: 1910-1920.
17. Kumar M, Hunag Y, Glinka Y, Prud'homme GJ, Wang Q, (2007) Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice. Gene Ther 14: 162-172.
18. Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, et al. (2003) Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80: 148-158.
19. Chan SJ, Seino S, Gruppuso PA, Schwartz R, Steiner DF, (1987) A mutation in the B chain coding region is associated with impaired proinsulin conversion in a family with hyperproinsulinemia. Proc Natl Acad Sci U S A 84: 2194-2197.
20. Carroll RJ, Hammer RE, Chan SJ, Swift HH, Rubenstein AH, et al. (1988) A mutant human proinsulin is secreted from islets of Langerhans in increased amounts via an unregulated pathway. Proc Natl Acad Sci U S A 85: 8943-8947.
21. Gross DJ, Halban PA, Kahn CR, Weir GC, Villa-Komaroff L, (1989) Partial diversion of a mutant proinsulin (B10 aspartic acid) from the regulated to the constitutive secretory pathway in transfected AtT-20 cells. Proc Natl Acad Sci U S A 86: 4107-4111.
22. Lazarus NR, Penhos JC, Tanese T, Michaels L, Gutman R, et al. (1970) Studies on the biological activity of porcine proinsulin. The Journal of Clinical Investigation 49: 487-496.
23. Stoll RW, Touber JL, Winterscheid LC, Ensinck JW, Williams RH, (1971) Hypoglycemic activity and immunological half-life of porcine insulin and proinsulin in baboons and swine. Endocrinology 88: 714-717.
24. Zheng C, Baum BJ, (2005) Evaluation of viral and mammalian promoters for use in gene delivery to salivary glands. Mol Ther 12: 528-536.
25. Brown AM, Rusnock EJ, Sciubba JJ, Baum BJ, (1989) Establishment and characterization of an epithelial cell line from the rat submandibular gland. J Oral Pathol Med 18: 206-213.
26. Hamaguchi K, Gaskins HR, Leiter EH, (1991) NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes 40: 842-849.
27. Mastrangeli A, O'Connell B, Aladib W, Fox PC, Baum BJ, et al. (1994) Direct in vivo adenovirus-mediated gene transfer to salivary glands. Am J Physiol 266: G1146-1155.
28. Marcovina S, Bowsher RR, Miller WG, Staten M, Myers G, et al. (2007) Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. Clin Chem 53: 711-716.
29. Cawley NX, Rodriguez YM, Maldonado A, Loh YP, (2003) Trafficking of mutant carboxypeptidase E to secretory granules in a beta-cell line derived from Cpe(fat)/Cpe(fat) mice. Endocrinology 144: 292-298.
30. Burgering BM, Coffer PJ, (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-602.
31. Rowzee AM, Ludwig DL, Wood TL, (2009) Insulin-like growth factor type 1 receptor and insulin receptor isoform expression and signaling in mammary epithelial cells. Endocrinology 150: 3611-3619.
32. Adriaansen J, Perez P, Zheng C, Collins MT, Baum BJ, (2011) Human parathyroid hormone is secreted primarily into the bloodstream after rat parotid gland gene transfer. Hum Gene Ther 22: 84-92.
33. Smeekens SP, Montag AG, Thomas G, Albiges-Rizo C, Carroll R, et al. (1992) Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. Proc Natl Acad Sci U S A 89: 8822-8826.
34. Steiner DF, Rouille Y, Gong Q, Martin S, Carroll R, et al. (1996) The role of prohormone convertases in insulin biosynthesis: evidence for inherited defects in their action in man and experimental animals. Diabetes Metab 22: 94-104.
35. Naggert JK, Fricker LD, Varlamov O, Nishina PM, Rouille Y, et al. (1995) Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 10: 135-142.
36. Chen H, Jawahar S, Qian Y, Duong Q, Chan G, et al. (2001) Missense polymorphism in the human carboxypeptidase E gene alters enzymatic activity. Hum Mutat 18: 120-131.
37. Cawley NX, Zhou J, Hill JM, Abebe D, Romboz S, et al. (2004) The carboxypeptidase E knockout mouse exhibits endocrinological and behavioral deficits. Endocrinology 145: 5807-5819.
38. Cawley NX, Wetsel WC, Murthy SR, Park JJ, Pacak K, et al. (2012) New roles of carboxypeptidase e in endocrine and neural function and cancer. Endocr Rev 33: 216-253.
39. Gabbay KH, DeLuca K, Fisher JN Jr, Mako ME, Rubenstein AH, (1976) Familial hyperproinsulinemia. An autosomal dominant defect. N Engl J Med 294: 911-915.
40. Roder ME, Vissing H, Nauck MA, (1996) Hyperproinsulinemia in a three-generation Caucasian family due to mutant proinsulin (Arg65-His) not associated with imparied glucose tolerance: the contribution of mutant proinsulin to insulin bioactivity. J Clin Endocrinol Metab 81: 1634-1640.
41. Schwartz GP, Burke GT, Katsoyannis PG, (1987) A superactive insulin: [B10-aspartic acid]insulin(human). Proc Natl Acad Sci U S A 84: 6408-6411.
42. Zheng C, Vitolo JM, Zhang W, Mineshiba F, Chiorini JA, et al. (2008) Extended transgene expression from a nonintegrating adenoviral vector containing retroviral elements. Mol Ther 16: 1089-1097.
43. Malaguarnera R, Sacco A, Voci C, Pandini G, Vigneri R, et al. (2012) Proinsulin binds with high affinity the insulin receptor isoform A and predominantly activates the mitogenic pathway. Endocrinology 153: 2152-2163.
44. Bavenholm P, Proudler A, Tornvall P, Godsland I, Landou C, et al. (1995) Insulin, intact and split proinsulin, and coronary artery disease in young men. Circulation 92: 1422-1429.
45. Hermann LS, Ranstam J, Vaaler S, Melander A, (1999) Effects of antihyperglycaemic therapies on proinsulin and relation between proinsulin and cardiovascular risk factors in type 2 diabetes. Diabetes Obes Metab 1: 227-232.
46. Yudkin JS, May M, Elwood P, Yarnell JW, Greenwood R, et al. (2002) Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly Study. Diabetologia 45: 327-336.
47. Strawbridge RJ, Dupuis J, Prokopenko I, Barker A, Ahlqvist E, et al. (2011) Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes 60: 2624-2634.